UBS Financial Raises Eastman Chemical to 'Buy'

Analyst Andy Cash says he believes management will restructure the underperforming CASPI businesses

UBS Financial upgraded Eastman Chemical (EMN ) to buy from neutral. Analyst Andy Cash says he believes CEO Brian Ferguson, with board support, will restructure the underperforming CASPI businesses, which have been a drag on condolidated EPS. He says EMN's earnings bottomed-out with the convergence of 1) money losing acquisitions; 2) high, volatile hydrocarbon costs; 3) large increases in PET capacity.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.